If you need more lookups,
subscriptions start at $34 USD/month.
Johan Lundqvist Location
Uppsala, SE
Johan Lundqvist Work
President @ (April 2026 - Present)
Co-founder and CEO @ (December 2019 - Present)
Professor of Toxicology @ (December 2024 - Present)
Associate Professor of Molecular Toxicology, @ (June 2018 - December 2024)
Researcher @ (February 2015 - December 2024)
Postdoctoral Fellow @ (August 2013 - January 2015)
Dietary Supplements Admission Evaluation and Labeling Expert Committee Member @ (July 2020 - June 2025)
Chair of Traffic and community environment board @ (January 2015 - December 2018)
Member of City council @ (January 2010 - December 2018)
2nd Deputy Chair of Board of roads and transportation @ (January 2011 - December 2011)
Guest Researcher @ (February 2016 - April 2016)
Postdoc, guest scientist @ (November 2011 - August 2013)
Visiting scholar @ (October 2012 - January 2013)
Assistant with research duties (postdoctoral) @ (June 2011 - October 2011)
PhD student @ (May 2006 - June 2011)
Political advisor to the vice-Mayor @ (January 2005 - January 2006)
Pharmacist @ (January 2005 - January 2005)
Johan Lundqvist Education
Uppsala University
PhD (Pharmaceutical Biochemistry)
2006-2011
Uppsala University
MSc (Pharmacy)
1999-2005
Johan Lundqvist Skills
Biochemistry
Cell Culture
ELISA
Life Sciences
Lifesciences
Molecular Biology
PCR
Pharmacology
Politics
Protein Purification
Research
Scientific Writing
Teaching
Toxicology
Western Blotting
qPCR
Johan Lundqvist Summary
Johan Lundqvist, based in Uppsala, SE, is currently a President at Swedish Society of Toxicology (SFT). Johan Lundqvist brings experience from previous roles at BioCell Analytica and SLU - Swedish University of Agricultural Sciences. Johan Lundqvist holds a 2006 - 2011 PhD in Pharmaceutical Biochemistry @ Uppsala University. With a robust skill set that includes Biochemistry, Cell Culture, ELISA, Life Sciences, Lifesciences and more. Johan Lundqvist has 1 emails on RocketReach.
Looking for a different Johan Lundqvist?
Find contact details for 700 million professionals.